Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TERT | O14746 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10837134 | 0.87 | FAAH (0.56) | FAAHTRPV1SOAT1CYP1A2CYP2C19 | |
| SCHEMBL7544355 | 0.87 | FAAH (0.56) | FAAHTRPV1SOAT1CYP1A2CYP2C19 | |
| SCHEMBL11089446 | 0.85 | FAAH (0.54) | FAAHTRPV1SOAT1CYP1A2CYP2C19 | |
| SCHEMBL1362596 | 0.85 | FAAH (0.54) | FAAHTRPV1SOAT1CYP1A2CYP2C19 | |
| SCHEMBL22022986 | 0.84 | KDM4E (0.50) | SOAT1CYP3A4KDM4EHSD17B10FABP4 | |
| SCHEMBL9319029 | 0.84 | FDPS (0.44) | KMT2AMEN1 | |
| SCHEMBL7480260 | 0.82 | DNM1 (0.48) | KMT2AMEN1 | |
| SCHEMBL29913359 | 0.82 | DNM1 (0.48) | KMT2AMEN1 | |
| SCHEMBL9453335 | 0.82 | DNM1 (0.48) | KMT2AMEN1 | |
| SCHEMBL8952970 | 0.82 | DNM1 (0.48) | KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250099480-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD | CORMEDIX INC (US) | 2025-03-27 | — | — | US | disclosed |
| US-12016865-B2 | Methods and pharmaceutical compositions for treating candida auris in blood | CORMEDIX INC. (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3313857-B1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPOSEUTICALS INC | 2020-11-17 | — | — | US | disclosed |
| EP-3727393-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD | CorMedix Inc. (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-3077006-B1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2020-08-19 | — | — | EP | disclosed |
| US-20190192529-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD | CORMEDIX INC. | 2019-06-27 | — | — | US | disclosed |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | LIPOSEUTICALS INC | 2018-09-04 | — | — | US | disclosed |
| EP-2673000-B1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3313857-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | Wu, Nian (US) | 2018-05-02 | — | — | EP | disclosed |
| EP-2673000-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | Wu, Nian (US) | 2013-12-18 | — | — | EP | disclosed |
| WO-2013003306-A1 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | WU NIAN (US) | 2013-01-03 | — | — | WO | disclosed |
| US-20130004592-A1 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | LIPOSEUTICALS, INC. | 2013-01-03 | — | — | US | disclosed |
| US-8304565-B2 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2012-11-06 | — | — | US | disclosed |
| WO-2012109112-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | disclosed |
| WO-2012109052-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | disclosed |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPOSEUTICALS, INC. | 2012-08-09 | — | — | US | disclosed |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-09 | — | — | US | disclosed |
| WO-2011139343-A2 | AMINO ACID LINKED PEG-LIPID CONJUGATES | WU NIAN (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | DAGLA, DAGLB, DGKG | FAAH 190/4885TRPV1 3253/4885SOAT1 401/4885 |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPC, FABP4, CETP | FAAH 39/4885TRPV1 3117/4885SOAT1 208/4885 |
| US-20130004592-A1 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | LIPC, CETP, UGCG | FAAH 1215/4885TRPV1 4452/4885SOAT1 488/4885 |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | CETP, FABP4, PLIN3 | FAAH 549/4885TRPV1 2624/4885SOAT1 97/4885 |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | FAAH 296/4885TRPV1 2912/4885SOAT1 293/4885 |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | FAAH 296/4885TRPV1 2912/4885SOAT1 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.